Quadrant Capital Group
COLL icon

Quadrant Capital Group’s Collegium Pharmaceutical COLL Stock Holding History

Quadrant Capital Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-6,714
Closed -$243K – 1242
2026
Q2 		$243K Sell
6,714
-286
-4% -$9.8K 0.01% 1155
2026
Q1 		$231K Buy
7,000
+4
+0.1% +$169 0.01% 1221
2025
Q4 		$324K Buy
6,996
+282
+4% +$11.8K 0.01% 1126
2025
Q3 		$235K Buy
+6,714
New +$233K 0.01% 1218
2025
Q2 		– Sell
-7,218
Closed -$215K – 1614
2025
Q1 		$215K Buy
7,218
+7,076
+4,983% +$216K 0.01% 1256
2024
Q4 		$4.07K Hold
142
– – ﹤0.01% 2354
2024
Q3 		$5.49K Hold
142
– – ﹤0.01% 2298
2024
Q2 		$4.57K Hold
142
– – ﹤0.01% 2313
2024
Q1 		$5.51K Hold
142
– – ﹤0.01% 2283
2023
Q4 		$4.37K Sell
142
-17
-11% -$426 ﹤0.01% 2310
2023
Q3 		$3.55K Buy
159
+17
+12% +$388 ﹤0.01% 2257
2023
Q2 		$3.05K Sell
142
-16
-10% -$363 ﹤0.01% 2319
2023
Q1 		$3.79K Buy
158
+16
+11% +$424 ﹤0.01% 2291
2022
Q4 		$3.29K Buy
142
+123
+647% +$2.48K ﹤0.01% 2302
2022
Q3 		$0 Buy
+19
New +$335 ﹤0.01% 2656
2022
Q2 		– Sell
-22
Closed – – 2568
2022
Q1 		$0 Buy
+22
New +$416 ﹤0.01% 2518

Other funds holding COLL

Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Kendall Capital Management
Kendall Capital Management Rockville, Maryland $605M AUM 38.16% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Quadrant Capital Group's COLL Position: Q3 2026 in Review

Quadrant Capital Group sold out of Collegium Pharmaceutical (COLL) in Q3 2026, closing a stake of 6,714 shares — an estimated $243K sold.

Quadrant Capital Group first reported a position in COLL in Q1 2022 and held it in 16 quarters. The position peaked at $324K in Q4 2025. 30 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Quadrant Capital Group reported no remaining Collegium Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 6,714 Collegium Pharmaceutical shares in Q3 2026, an estimated $243K.
  • Quadrant Capital Group first reported a position in Collegium Pharmaceutical in Q1 2022 and held it in 16 quarters.
  • Quadrant Capital Group's Collegium Pharmaceutical position peaked at $324K in Q4 2025.
  • 30 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Quadrant Capital Group's 13F filing for Q3 2026, filed 20 Oct 2026.